Hannah M. Linden

发表

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

H. Linden, G. Hortobagyi, D. Tripathy, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency.

G. Hortobagyi, P. Sharma, S. Stecklein, 2023, JCO precision oncology.